Journal Article Ahead of print
PubMed: 42663056 DOI: 10.1093/eurheartj/ehag739
Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
Eur Heart J
Authors: Gaetano M De Ferrari, Robert P Giugliano, Lawrence A Leiter, Jose C Nicolau, Ajay Bhatia, Marcoli Cyrille, Jeong-Gun Park, Julia F Kuder, Sabina A Murphy, Lyrica Liu, Huei Wang, Andrzej Budaj, Jan Cornel, Andrej Džupina, Andrejs Erglis, Henrik K Jensen, Robert Gabor Kiss, Johanna Kuusisto, Jose Lopez-Sendon, Alberto Lorenzatti, Giles Montalescot, Stephen Nicholls, Alexandr Parkhomenko, Axel Sigurdsson, Margus Viigimaa, Gabriel Paiva da Silva Lima, Marc S Sabatine, Erin A Bohula
Affiliations
- Cardiology Division, Department of Medical Sciences, University of Torino and Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino Italy.
- TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
- Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo.
- Amgen, Thousand Oaks, CA.
- Department of Cardiology, Centre of Postgraduate Medical Education, Grochowski Hospital, Warsaw, Poland.
- Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar and Radboudumc, Nijmegen, the Netherlands.
- Department of Angiology, Comenius University and National Institute of Cardiovascular Diseases, Bratislava, Slovakia.
- Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia.
- Department of Cardiology, Aarhus University Hospital and Department of Clinical Medicine, Health, Aarhus University, Aarhus N, Denmark.
- Cardiovascular Center, Semmelweis University, Budapest, Hungary.
- Centre for Medicine and Clinical Research, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
- Idipaz Research Institute. Cardiology Hospital La Paz, Universidad Autonoma de Madrid. Spain.
- DAMIC Medical Institute & Rusculleda Foundation for Research, Cordoba, Argentina.
- ACTION Study Group, Sorbonne University, AP-HP, Hôpital Pitié-Salpétrière, Paris, France.
- Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.
- National Scientific Center named after M.D.Strazhesko, Kyiv, Ukraine.
- University of Iceland, Reykjavik, Iceland.
- North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia.
MeSH
Myocardial Infarction, Cardiology